Question 1

What is the CA-62 cancer test?

Accepted Answer

The CA-62 test is a blood-based cancer screening test that measures the CA-62 N-glycoprotein biomarker. It detects early-stage epithelial cancers with over 90% sensitivity at Stage I and II. It is available direct-to-consumer for $300 with at-home nurse blood draw service.

Question 2

How does CA-62 compare to Galleri (GRAIL)?

Accepted Answer

CA-62 demonstrates over 90% sensitivity for Stage I and II cancers, while Galleri has published early-stage sensitivity of approximately 27.5–37.3% (The Lancet, 2024). CA-62 is also significantly more affordable at $300 versus Galleri's $949, requires no prescription, and also detects pre-cancerous conditions.

Question 3

How does the at-home CA-62 test work?

Accepted Answer

Order online at tryucm.com. A certified nurse visits your home within 70–120 hours to perform a simple blood draw. Your sample is analyzed in a CLIA-certified laboratory. Results are delivered securely to your online account in approximately 10 days.

Question 4

Do I need a prescription for the CA-62 test?

Accepted Answer

No. The CA-62 test can be ordered directly online without a doctor's prescription or referral.

Question 5

How much does the CA-62 test cost?

Accepted Answer

The CA-62 test costs $300 all-inclusive — this covers the test kit, certified nurse home visit, laboratory analysis, and your online results report. There are no hidden fees.

Question 6

What cancers does the CA-62 test detect?

Accepted Answer

CA-62 is a universal epithelial cancer marker that can detect breast cancer, prostate cancer, lung cancer, colorectal cancer, ovarian cancer, endometrial cancer, renal cell carcinoma, and other epithelial carcinomas. It also detects pre-cancerous conditions such as adenomatous polyps.

Your Questions, Answered

About the Test

Ordering & Process

Results & Follow-Up

Pricing & Insurance

Still Have Questions?

Ready to Get Screened?